S1 Ep37: Increasing Testing Access and Guiding Treatment Options with TrialJectory
S2 Ep14: Treatment Options for Relapsed/Refractory Small Cell Lung Cancer
S1 Ep36: Value of Geriatric Assessment in Patients With Genitourinary Carcinoma
S1 Ep35: Germline Testing in Prostate Cancer: When and Who to Test
S2 Ep13: First-Line Therapeutic Options in Small Cell Lung Cancer
S2 Ep12: OncView™ Podcast: Connie Batlevi, MD, PhD on R/R Follicular Lymphoma Therapy Updates
S1 Ep34: Debra Patt, MD, PhD, MBA, FASCO, on Telehealth in Cancer Care
S2 Ep11: Between the Lines: PET/CT-Guided Postprostatectomy Salvage Radiotherapy for Prostate Cancer
S1 Ep33: Plasma Glutamine as a Prognostic Biomarker in Localized Prostate Cancer
S1 Ep32: ScaleReady’s Work to Make Cell and Gene Therapy Practical and Viable
S1 Ep31: Inside the Advancing Inclusive Research Site Alliance for Clinical Trial Diversity
S2 Ep10: Two Experts Review Important R/R DLBCL Treatment Decisions and Data
S2 Ep9: OncView™ Podcast: Updates in Therapies of Relapsed/Refractory Follicular Lymphoma
S2 Ep8: OncView™ Podcast: NCCN Guideline Updates in HR+ Breast Cancer
S1 Ep30: Routine Breast Cancer Screening in Average-Risk Women Younger Than 50 Years
S1 Ep29: Examining Evidence Underlying the NCCN Guidelines for Hematologic Malignancies
S2 Ep7: Kami Maddocks, MD, on Rituximab Rechallenging and Second-Line Therapies for R/R DLBCL
S1 Ep28: Considering Second-Line Treatment Amidst Evolving Frontline Landscape for Clear Cell RCC
S2 Ep6: OncView™ Podcast: Updates in Managing Extensive-Stage Small Cell Lung Cancer
S1 Ep27: BPCIA, 4-Letter Suffix Rule, & the Challenges of Biosimilar Prescription
S2 Ep5: Emerging and Existing Treatment Regimens for Transplant-Ineligible DLBCL
S2 Ep4: OncView Podcast: Front-Line Management of Extensive-Stage SCLC
S1 Ep26: Molecular Profiling Practices in Pancreatic Adenocarcinoma
S2 Ep3: OncView™ Podcast: Management of Relapsed/Refractory Follicular Lymphoma
S1 Ep25: Primary Focal Therapy for Localized Prostate Cancer
S1 Ep24: Treatment Considerations for Transplant-Ineligible Multiple Myeloma
S2 Ep2: OncView Podcast: Optimizing Treatment With Extended Adjuvant Therapy for HR+ Breast Cancer
S2 Ep1: OncView Podcast: Genomic Testing in HR+ Breast Cancer to Guide Therapy in the Extended Adjuvant Setting
S1 Ep23: A Critical Interval to Delay Progression of Prostate Cancer
S1 Ep22: Integrating PARP Inhibitors Into Advanced Prostate Cancer Therapeutics
S1 Ep21: 1-on-1 with David Johnson: Enveric's Endocannabinoid Products for Glioblastoma
S1 Ep20: COVID-19, Cancer, and the Potential of mRNA Vaccines
S1 Ep19: Impact of Treatment Refusal on Survival for Small Cell Lung Cancer
S1 Ep18: 1-on-1 with Richard Schilsky, MD: Molecular Profiling in GI Cancers
S1 Ep17: Utility of 21-Gene Recurrence Score for Node-Positive Breast Cancer
S1 Ep16: Mediterranean Diet's Association with Localized Prostate Cancer
S1 Ep15: Guidelines for Palliative Treatment of Spinal Metastases
S1 Ep14: 1-on-1 with Che-Kai Tsao, MD: Smoking Cessation and Patient Screening
S1 Ep13: Recommending Patient-Reported Outcomes of Pain for Cancer Care
S1 Ep12: 1-on-1 with Zuri Murrell, MD: Colorectal Cancer in Black Patients
S1 Ep11: Fertility Preservation Decision-Making for Adolescents with Cancer
S1 Ep10: Barriers to Pancreatic Cancer Clinical Trial Enrollment
S1 Ep9: Cancer Care Management During the COVID-19 Pandemic
S1 Ep8: The Psychological Aspect of Patients in Phase 1 Clinical Trials
S1 Ep7: Molecular Profiling in Metastatic Colorectal Cancer
S1 Ep6: 1-on-1 with Dr. Michael Randell: New ACS Guidelines for Cervical Cancer
S1 Ep5: Is Next-Generation Sequencing a Right for Patients with GI Cancers?
S1 Ep4: The COVID-19 Pandemic's Impact on Cancer Screenings
S1 Ep3: Clinical Trials System and the COVID-19 Pandemic
S1 Ep2: 1-on-1 with Dr. Xu Ji: Mental Health Among Cancer Survivors
next page